Showing results (501-510 of 4,558) with videos related to
Sort By:
Pageof 456
Neuropsychiatric Disease and Treatment|May 5, 2009
Cognitive deficits and functional outcome in schizophreniaChristopher R Bowie, Philip D HarveyNeuropsychiatric Disease and Treatment|May 28, 2010
Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesisE Ece Boylu, R Erdem Toğrol, Mehmet Güney Senol, et al.Neuropsychiatric Disease and Treatment|August 4, 2009
Treatment of obese patients with binge eating disorder using topiramate: a reviewPaolo Leombruni, Luca Lavagnino, Secondo FassinoNeuropsychiatric Disease and Treatment|September 2, 2009
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorderAlla Avedisova, Vladimir Borodin, Ksenia Zakharova, et al.Neuropsychiatric Disease and Treatment|September 2, 2009
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochlorideRajasree Nair, Shannon B MossNeuropsychiatric Disease and Treatment|September 2, 2009
Computerized assessment of pain drawing area: A pilot studyAnna Wenngren, Britt-Marie StålnackeNeuropsychiatric Disease and Treatment|August 9, 2011
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the NetherlandsBart Hoogveldt, Benoît Rive, Johan Severens, et al.Neuropsychiatric Disease and Treatment|August 9, 2011
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophreniaMário Rodrigues Louzã, Helio Elkis, Sandra Ruschel, et al.Neuropsychiatric Disease and Treatment|September 21, 2011
Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary studyNapapon Sailasuta, Kent Harris, Thao Tran, et al.Neuropsychiatric Disease and Treatment|September 21, 2011
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosisClemens Warnke, Olaf Stüve, Hans-Peter Hartung, et al.Pageof 456